Trinity Nuclein Series C QP Investors LLC
Other TechnologyBiotechnology and Diagnostics
Southlake, TX
2025
founded
About
Trinity Nuclein Series C QP Investors LLC is an investment entity associated with Trinity Investors, a distinguished private equity firm. This vehicle is primarily aimed at funding Nuclein, a biotechnology innovator dedicated to creating advanced rapid diagnostic testing solutions for infectious diseases.
Company Values
Trinity Nuclein stands out by enabling healthcare providers to obtain rapid, lab-quality diagnostic results in just 15 minutes, significantly reducing the waiting times associated with traditional testing methods.